abmart-banner
Global R&D Pipeline
My Favorite
Hot Targets:
Home>AbMart>

Global R&D Pipeline

GnRHR
Back
Total number of drugs
113
Phase II and later clinical stages
29.2%
Involving companies
167
Main therapeutic areas
Neoplasms
Data Table
Data Chart
Select Row
Fixed Column
Download Table
Molecule Info
R&D and Market Info
ADC Info
DrugDrug Name EnDrug TypeTreatment FieldMechanism of ActionOriginatorDeveloperIndicationHighest Development StageHighest Development Stage (China)Approved Countries/RegionsApproved TimeApproved Time (China)Special ReviewADC TypeADC LinkerADC PayloadADC DARDrug NameAntibody TypeADC Linking SiteOperation
Org-30850Org-30850Synthetic peptideOther DiseasesGonadotropin-releasing hormone receptor agonistsMerck Sharp & Dohme Corp.DiscontinuedOrg-30850
detail  >
Human luteinizing hormone releasing hormone-exotoxin of pseudomonas aeruginosa fusion proteinHuman luteinizing hormone releasing hormone-exotoxin of pseudomonas aeruginosa fusion proteinFusion proteinNeoplasmsGonadotropin-releasing hormone receptor antagonistsShenzhen Gaoke Biotechnology Co., Ltd.IND ApplicationIND ApplicationHuman luteinizing hormone releasing hormone-exotoxin of pseudomonas aeruginosa fusion protein
detail  >
IturelixIturelixSynthetic peptideNeoplasms Urogenital DiseasesGonadotropin-releasing hormone receptor antagonistsMerck Serono SADiscontinuedIturelix
detail  >
LHRH-PE40LHRH-PE40Fusion proteinNeoplasmsElongation factor 2 inhibitors Gonadotropin-releasing hormone receptor antagonistsJilin Yatai (Group) Co., Ltd.DiscontinuedDiscontinuedLHRH-PE40
detail  >
Nal-GluNal-GluChemical drugsGonadotropin-releasing hormone receptor antagonistsThe Salk Institute for Biological StudiesDiscontinuedNal-Glu
detail  >
NBI-42902NBI-42902Small molecule drugNeoplasms Skin and Musculoskeletal Diseases Urogenital DiseasesGonadotropin-releasing hormone receptor antagonistsNeurocrine Biosciences, Inc.DiscontinuedNBI-42902
detail  >
NBI-70631NBI-70631Small molecule drugUrogenital DiseasesGonadotropin-releasing hormone receptor antagonistsNeurocrine Biosciences, Inc.DiscontinuedNBI-70631
detail  >
OpigolixOpigolixSmall molecule drugImmune System Diseases Nervous System Diseases Skin and Musculoskeletal Diseases Urogenital Diseases Other DiseasesGonadotropin-releasing hormone receptor antagonistsAstellas Pharma, Inc.Phase 2Opigolix
detail  >
T-66T-66Small molecule drugNeoplasms Urogenital DiseasesGonadotropin-releasing hormone receptor agonistsMatrix TherapeuticsDiscontinuedT-66
detail  >
SufugolixSufugolixSmall molecule drugNeoplasms Urogenital DiseasesGonadotropin-releasing hormone receptor antagonistsTakeda Pharmaceutical Co., Ltd.DiscontinuedSufugolix
detail  >
Total 113 data
1
2
3
4
5
6
...
11
12